Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Actavis Inc    

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on ACTAVIS INC
2016DJMARKET SNAPSHOT : Stocks Back Off All-time Highs As Health-care Stocks Slump
2016DJMARKET SNAPSHOT : Stocks Retreat From Records As Health-care Stocks Slump
2016DJU.S. Stocks Slip Despite Surge in Energy Sector
2016DJPFIZER : Business Groups Sue Over Inversion Rules -- WSJ
2016DJPFIZER : Business Groups Sue U.S. Government Over Tax-Inversion Rules -- 2nd Upd..
2016 Business groups sue over new U.S. limit on tax-driven foreign buyouts
2016DJPFIZER : Business Groups Sue U.S. Government Over Tax-Inversion Rules -- Update
2016DJPFIZER : Business Groups Sue U.S. Government Over Tax-Inversion Rules
2016DJPFIZER : U.S. Government Sued Over Tax-Inversion Rules
2016 Teva Pharm eyes more acquisitions after buying Allergan's generics business
2016DJTEVA PHARMACEUTICAL : Profit Falls on Write-Downs
2016DJTEVA PHARMACEUTICAL : Business Watch -- WSJ
2016 Allergan to sell Anda drug distribution business to Teva
2016ALLERGAN PLC : half-yearly earnings release
2016DJTEVA PHARMACEUTICAL : to Buy Generics Distributor Anda From Allergan for $500 Mi..
2016DJTEVA PHARMACEUTICAL : to Buy Generics Distributor Anda From Allergan for $500 Mi..
2016DJPFIZER : Hit As Sales Of Older Drugs Fall -- WSJ
2016DJBiogen Draws Takeover Interest from Rival Drugmakers--2nd Update
2016DJBiogen Draws Takeover Interest from Rival Drugmakers--2nd Update
2016DJBiogen Draws Takeover Interest from Rival Drugmakers--Update
2016DJBiogen Draws Takeover Interest from Rival Drugmakers
2016DJPfizer Results Beat Expectations
2016DJPFIZER : Profit Surprises as New Product Sales Rise
2016DJFacebook Rides Mobile-Ad Surge -- WSJ
2016 Teva, Allergan win U.S. antitrust approval for generics deal
2016DJTEVA PHARMACEUTICAL : Correction to Teva, Allergan Article
2016DJTEVA PHARMACEUTICAL : Allergan Get FTC Approval for Generics Purchase
2016DJAmgen and Allergan Study Finds Biosimilar Comparable to Herceptin
2016DJJOHNSON & JOHNSON : Jury Acquits Former Johnson & Johnson Unit Executives of Fel..
2016DJJOHNSON & JOHNSON : Jury Acquits Former Johnson & Johnson Unit Executives of Fel..
2016 SoftBank bid for ARM catches some hedge funds off guard
2016DJTEVA PHARMACEUTICAL : Sells $15 Billion of Bonds
2016DJTEVA PHARMACEUTICAL : Finalizes Bond Sale -- Update
2016DJTEVA PHARMACEUTICAL : Finalizes Bond Sale
2016DJTeva Sells $15 Billion of Bonds
2016DJTEVA PHARMACEUTICAL : Allergan Tweak Acquisition Agreement
2016DJTEVA PHARMACEUTICAL : Allergan Tweak Acquisition Agreement
2016DJTeva Raises Guidance
2016DJTEVA PHARMACEUTICAL : Raises Guidance
2016 Shire on a roll as U.S. approves keenly awaited eye drug
2016 EXCLUSIVE - WELLCARE, CENTENE MAKE O : sources
2016DJMayne Pharma Buys US Drugs from Teva, Allergan for $652 Million
2016DJTeva and Allergan Sell Generic Drugs to Impax In Latest Divestiture
2016DJTeva and Allergan Sell Generic Drugs to Impax In Latest Divestiture
2016DJALLERGAN : Former Warner Chilcott Executive Acquitted of Kickbacks Charge
2016DJTeva, Looking to Close Actavis Deal, Sells $40 Million Portfolio to Sagent
2016DJLILLY : German Supreme Court Grants Appeal in Dispute With Actavis
2016DJALLERGAN : Icahn Takes Big Stake in Allergan, Endorses Drugmaker's CEO
2016 Anacor received rival bid before Pfizer deal - filing
2016DJPfizer Buys Anacor In Turn to Smaller Deals -- WSJ
2016DJPfizer to Buy Anacor for $4.5 Billion--2nd Update
2016DJPfizer to Buy Anacor for $4.5 Billion--Update
2016DJPfizer to Buy Anacor for $4.5 Billion
2016DJPfizer to Buy Anacor for $4.5 Billion
2016 Baupost took $461 million Allergan stake before Pfizer deal collapsed
2016DJMarkit's Profit Falls on Higher Personnel Costs
2016DJALLERGAN : Uterine Fibroids Treatment Shows Efficacy
2016DJTEVA PHARMACEUTICAL : Revenue Declines as Some Drugs Lose Exclusivity
2016DJEndo Cuts Annual Guidance on Impairment Charge
2016DJPFIZER : Reports Rock-Solid Quarter, Sees Stronger Year Ahead
2016DJPfizer Guides Higher, Mulls Breakup of Company
2016DJNew Tax Inversion Rules Complicate Equipment-Maker Deal
2016DJJOSEPH PAPA : Valeant Names Joseph Papa as New CEO
2016DJAllergan Completes Licensing Deal After Pfizer Bid Collapses
2016DJAllergan Completes Licensing Deal After Pfizer Bid Collapses
2016 Mega deals morph into mega problems for Wall Street
2016DJPfizer, Allergan to Hunt for Deals of Their Own
2016 Oil, healthcare boost stocks; dollar weak after minutes
2016 Oil, healthcare boost global stocks; dollar weak after minutes
2016DJPFIZER : Treasury Has Outsize Legal Leverage on Inversions
2016DJFDA Approves Medtronic Pacemaker That Attaches Directly to Heart
2016 Mega-deal collapse a second-quarter wake-up for merger-arb hedge funds
2016DJAllergan CEO Saunders Criticizes Treasury Rules That Scuttled Pfizer Deal
2016DJPFIZER : Allergan End Merger Agreement -- 2nd Update
2016 Democratic White House hopefuls cheer end of Pfizer, Allergan deal
Advertisement
Financials ($)
Sales 2017 15 806 M
EBIT 2017 7 607 M
Net income 2017 -1 759 M
Debt 2017 16 935 M
Yield 2017 1,17%
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 6,31x
EV / Sales 2018 5,87x
Capitalization 82 778 M
More Financials
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 270 $
Spread / Average Target 9,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Brenton L. Saunders Chairman, President & Chief Executive Officer
Robert A. Stewart Chief Operating Officer
Maria Teresa Hilado Chief Financial Officer
C. David Nicholson Chief Research & Development Officer
Paul M. Bisaro Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ACTAVIS INC82 778
JOHNSON & JOHNSON18.42%367 520
NOVARTIS13.09%225 386
ROCHE HOLDING LTD.8.68%224 497
PFIZER5.20%203 487
MERCK AND COMPANY12.38%180 958
More Results